- Home
- GDL vs FORA Comparison
GDL vs FORA Comparison
Compare GDL & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDL
- FORA
- Stock Information
- Founded
- GDL 2006
- FORA 2014
- Country
- GDL United States
- FORA United States
- Employees
- GDL N/A
- FORA N/A
- Industry
- GDL Investment Managers
- FORA Computer Software: Prepackaged Software
- Sector
- GDL Finance
- FORA Technology
- Exchange
- GDL Nasdaq
- FORA Nasdaq
- Market Cap
- GDL 96.8M
- FORA 77.6M
- IPO Year
- GDL N/A
- FORA N/A
- Fundamental
- Price
- GDL $8.34
- FORA $2.41
- Analyst Decision
- GDL
- FORA Strong Buy
- Analyst Count
- GDL 0
- FORA 1
- Target Price
- GDL N/A
- FORA $5.00
- AVG Volume (30 Days)
- GDL 11.2K
- FORA 57.0K
- Earning Date
- GDL 01-01-0001
- FORA 03-27-2025
- Dividend Yield
- GDL 6.02%
- FORA N/A
- EPS Growth
- GDL N/A
- FORA N/A
- EPS
- GDL N/A
- FORA N/A
- Revenue
- GDL N/A
- FORA $19,709,723.00
- Revenue This Year
- GDL N/A
- FORA N/A
- Revenue Next Year
- GDL N/A
- FORA $13.59
- P/E Ratio
- GDL N/A
- FORA N/A
- Revenue Growth
- GDL N/A
- FORA N/A
- 52 Week Low
- GDL $7.65
- FORA $1.96
- 52 Week High
- GDL $8.13
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- GDL 66.71
- FORA 48.34
- Support Level
- GDL $8.29
- FORA $2.35
- Resistance Level
- GDL $8.37
- FORA $4.03
- Average True Range (ATR)
- GDL 0.05
- FORA 0.45
- MACD
- GDL 0.01
- FORA -0.01
- Stochastic Oscillator
- GDL 82.61
- FORA 19.00
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.